Biotech firm Sonnet to form $888M HYPE treasury
Biotech firm Sonnet is merging with Rorschach to form Hyperliquid Strategies, which aims to become HYPE token’s largest United States-listed holder.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Biotech firm Sonnet is merging with Rorschach to form Hyperliquid Strategies, which aims to become HYPE token’s largest United States-listed holder.
Why this matters
This altcoin story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Hyperliquid founder wants U.S. oversight of trading platforms, not his blockchain
Jeff Yan told Bloomberg that U.S. regulatory oversight should apply to the firms using the blockchain, not to the underlying netwo...
Hyperliquid founder seeks US regulatory exemption for blockchain operations
Regulatory clarity could redefine blockchain market dynamics, influencing Hyperliquid's US operations and investor confidence sign...
Hyperliquid expands tokenized stock offerings with EQX launch
EQX plans to launch 11 tokenized US stocks and ETFs on Hyperliquid, offering 24/7 spot trading, share backing, dividend reinvestme...
S&P 500 options are the hottest bet on this Hyperliquid exchange
Hypercall, an exchange built on Hyperliquid, says most of its $640 million in volume since June has come from the index.
Tether Paid a Firm Owned by a Former White House Crypto Official, WSJ
A Wall Street Journal investigation alleges that Tether paid approximately $6.3 million to a consulting firm partly owned by Bo Hi...
EQX Plans 11 Tokenized Stock and ETF Markets on Hyperliquid
The share-backed tokens would trade on HyperCore against USDC, with US persons excluded under EQX’s eligibility rules.... Read the...